TSX closed
Loading markets…
Stocks/NASDAQ/BBH

VanEck Biotech ETF (BBH : NASDAQ)

ETF

$261.63

USD

+6.06 (2.37%)

Last updated: 2026-11-04

Follow BBH

BBH

VanEck Biotech ETF

Source:WealthAwesomeWealthAwesome
↑ $17.85 (7.32%)
30 day period
$234.03$247.83$261.63Sep 24Oct 15Nov 4

Key Statistics

Market Cap

$525.11M

52W High

$262.60

52W Low

$177.88

P/E Ratio

-

50 Day MA

$241.29

200 Day MA

$207.01

Beta

0.56

Dividend Yield

39.59%

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/4/2026$260.76$261.74$255.48$261.63$261.6318,112
11/3/2026$256.08$257.58$255.09$255.57$255.5719,800
11/2/2026$258.82$259.51$254.37$254.50$254.5023,600
10/30/2026$259.30$262.60$256.52$257.98$257.9832,300
10/29/2026$256.11$257.70$254.18$256.90$256.9011,300
10/28/2026$248.26$254.75$248.26$253.27$253.2719,400
10/27/2026$246.34$249.80$243.55$249.80$249.806,500
10/26/2026$246.77$247.39$245.73$247.39$247.3912,800
10/23/2026$247.53$247.69$246.05$246.57$246.574,900
10/22/2026$248.50$251.03$245.72$248.41$248.4117,500

About VanEck Biotech ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Financials

Revenue (TTM)
-
EBITDA
-
Profit Margin
-
ROE (TTM)
-
EPS (Diluted)
-
Book Value
-

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About BBH.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
INMInMed Pharmaceuticals Inc$17.50+941.67%
OMHOhmyhome Limited Ordinary Shares$15.55+432.53%
CRISCuris Inc$1.11+56.34%
PMAXPowell Max Limited Class A Ordinary Shares$1.04+54.07%
RFAIRRF Acquisition Corp II Right$0.24+50.00%
CRCTCricut Inc$8.88+48.74%
LYELLyell Immunopharma Inc$15.43+43.27%
GENVRGen Digital Inc. Contingent Value Rights$4.03+42.40%